A. Eden Evins
A. Eden Evins
Mass General Hospital and Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised …
RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ...
The Lancet 387 (10037), 2507-2520, 2016
Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review
ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ...
JAMA psychiatry 73 (3), 292-297, 2016
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis
DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ...
Archives of general psychiatry 62 (1), 19-28, 2005
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach
M Fava, AE Evins, DJ Dorer, DA Schoenfeld
Psychotherapy and psychosomatics 72 (3), 115-127, 2003
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.
DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ...
Journal of Clinical Psychiatry 66 (2), 183-194, 2005
Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence
AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ...
Biological psychiatry 67 (8), 722-729, 2010
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls
RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ...
Neuropsychopharmacology 33 (3), 480-490, 2008
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness
DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ...
Psychopharmacology 196 (2), 221-232, 2008
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study
DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ...
Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia
AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale
Nicotine & tobacco research 3 (4), 397-403, 2001
Placebo-controlled trial of glycine added to clozapine in schizophrenia
AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff
American Journal of Psychiatry 157 (5), 826-828, 2000
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia
AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ...
Journal of clinical psychopharmacology 25 (3), 218-225, 2005
Optimizing real time fMRI neurofeedback for therapeutic discovery and development
LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ...
NeuroImage: Clinical 5, 245-255, 2014
A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia
DC Goff, DC Henderson, AE Evins, E Amico
Biological psychiatry 45 (4), 512-514, 1999
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial
AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ...
Jama 311 (2), 145-154, 2014
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ...
Journal of clinical psychopharmacology 27 (4), 380-386, 2007
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight
O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff
Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004
Opioid antagonists for smoking cessation
SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska
Cochrane Database of Systematic Reviews, 2013
Folate, homocysteine, and negative symptoms in schizophrenia
DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ...
American Journal of Psychiatry 161 (9), 1705-1708, 2004
A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain
DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ...
American Journal of Psychiatry 162 (5), 954-962, 2005
The system can't perform the operation now. Try again later.
Articles 1–20